Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment. (2019)
Attributed to:
Lifecourse Determinants of Bone and Joint Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/1756-185x.13068
PubMed Identifier: 28332780
Publication URI: http://europepmc.org/abstract/MED/28332780
Type: Journal Article/Review
Volume: 22
Parent Publication: International journal of rheumatic diseases
Issue: 3
ISSN: 1756-1841